New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 23, 2014
14:03 EDTADXSAdvaxis treatment of osteosarcoma designated for orphan status
The company's live attenuated bioengineered Listeria monocytogenes immunotherapy was designated for orphan status as an osteosarcoma treatment, according to a post to the FDA's website. Reference Link
News For ADXS From The Last 14 Days
Check below for free stories on ADXS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for ADXS

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use